A randomized study of very accelerated radiotherapy with and without amifostine in head and neck squamous cell carcinoma

Autor:	J Bourhis, R de Crevoisier, B Abdulkarim, E Deutsch, A Lusinchi, B Luboinski, P Wibault, F Eschwege, D.M Brizel, T.H Wasserman, M Henke, V Strnad, V Rudat, A Monnier, J Zhang, L Russell, W Oster, R Sauer, M.I Koukourakis, G Kyrias, S Kakolyris, C Kouroussis, C Frangiadaki, A Giatromanolaki, G Retalis, V Georgoulias, E.Y Huang, S.W Leung, C.J Wang, H.C Chen, L.M Sun, F.M Fang, S.A Yeh, H.C Hsu, C.Y Hsiung, T.A Makkonen, H Minn, A Jekunen, P Vilja, J Tuominen, H Joensuu
Rok vydání:	2001
Předmět:	Oncology medicine.medical_specialty business.industry Amifostine medicine.disease Head and neck squamous-cell carcinoma law.invention Randomized controlled trial law Internal medicine Accelerated radiotherapy Medicine Radiology Nuclear Medicine and imaging business medicine.drug
Zdroj:	Cancer/Radiothérapie. 5:202-204
ISSN:	1278-3218
DOI:	10.1016/s1278-3218(00)00074-3
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::f9f1140ec9491977cfcaaaa2fe0a49bd https://doi.org/10.1016/s1278-3218(00)00074-3 Zobrazit plný text záznamu Full Text from ScienceDirect